Cargando…

Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: A randomized controlled trial

BACKGROUND: Intravenous oxycodone has been used as an adjunct to anesthetic agents. This study aimed to assess the optimal dose of intravenous oxycodone for the attenuation of the hemodynamic responses to laryngoscopy and endotracheal intubation. METHODS: A prospective, randomized, double-blind stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yong-Hee, Lee, Seung-Hyuk, Lee, Oh Haeng, Kang, Hyun, Shin, Hwa-Yong, Baek, Chong-Wha, Jung, Yong Hun, Woo, Young Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369887/
https://www.ncbi.nlm.nih.gov/pubmed/28296732
http://dx.doi.org/10.1097/MD.0000000000006234
_version_ 1782518140193734656
author Park, Yong-Hee
Lee, Seung-Hyuk
Lee, Oh Haeng
Kang, Hyun
Shin, Hwa-Yong
Baek, Chong-Wha
Jung, Yong Hun
Woo, Young Cheol
author_facet Park, Yong-Hee
Lee, Seung-Hyuk
Lee, Oh Haeng
Kang, Hyun
Shin, Hwa-Yong
Baek, Chong-Wha
Jung, Yong Hun
Woo, Young Cheol
author_sort Park, Yong-Hee
collection PubMed
description BACKGROUND: Intravenous oxycodone has been used as an adjunct to anesthetic agents. This study aimed to assess the optimal dose of intravenous oxycodone for the attenuation of the hemodynamic responses to laryngoscopy and endotracheal intubation. METHODS: A prospective, randomized, double-blind study was conducted. Ninety-five patients were randomly divided into 5 groups based on the oxycodone dose: 0, 0.05, 0.1, 0.15, 0.2 mg/kg. After administering the assigned dose of intravenous oxycodone, anesthesia was induced with thiopental. Heart rate (HR) and blood pressure (BP) were measured at baseline, before intubation, and 1, 2, and 3 minutes after intubation. The percentage increase of BP was calculated as (highest BP after intubation − baseline BP)/baseline BP × 100 (%). The percentage increase of HR was calculated in same formula as above. Hypertension was defined as a 15% increase of systolic BP from baseline, and probit analysis was conducted. RESULTS: Hemodynamic data from 86 patients were analyzed. The percentage increase of mean arterial pressure after intubation in groups 0.05, 0.1, 0.15, and 0.2 was significantly different from that in the control (P < 0.001). For HR, the percentage increase was lower than control group when oxycodone was same or more than 0.1 mg/kg (P < 0.05). Using probit analysis, the 95% effective dose (ED(95)) for preventing hypertension was 0.159 mg/kg (95% confidence interval [CI], 0.122–0.243). In addition, ED(50) was 0.020 mg/kg (95% CI, −0.037 to 0.049). However, oxycodone was not effective for maintaining the HR in our study dosage. There were no significant differences in the incidence of hypotension during induction between groups. CONCLUSIONS: Using 0.1 mg/kg of intravenous oxycodone is sufficient to attenuate the increase of BP and HR during induction period in healthy patients. The ED(95), which was 0.159 mg/kg, can be useful to adjust the dosage of IV oxycodone for maintain stable BP during induction of general anesthesia.
format Online
Article
Text
id pubmed-5369887
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-53698872017-03-31 Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: A randomized controlled trial Park, Yong-Hee Lee, Seung-Hyuk Lee, Oh Haeng Kang, Hyun Shin, Hwa-Yong Baek, Chong-Wha Jung, Yong Hun Woo, Young Cheol Medicine (Baltimore) 3300 BACKGROUND: Intravenous oxycodone has been used as an adjunct to anesthetic agents. This study aimed to assess the optimal dose of intravenous oxycodone for the attenuation of the hemodynamic responses to laryngoscopy and endotracheal intubation. METHODS: A prospective, randomized, double-blind study was conducted. Ninety-five patients were randomly divided into 5 groups based on the oxycodone dose: 0, 0.05, 0.1, 0.15, 0.2 mg/kg. After administering the assigned dose of intravenous oxycodone, anesthesia was induced with thiopental. Heart rate (HR) and blood pressure (BP) were measured at baseline, before intubation, and 1, 2, and 3 minutes after intubation. The percentage increase of BP was calculated as (highest BP after intubation − baseline BP)/baseline BP × 100 (%). The percentage increase of HR was calculated in same formula as above. Hypertension was defined as a 15% increase of systolic BP from baseline, and probit analysis was conducted. RESULTS: Hemodynamic data from 86 patients were analyzed. The percentage increase of mean arterial pressure after intubation in groups 0.05, 0.1, 0.15, and 0.2 was significantly different from that in the control (P < 0.001). For HR, the percentage increase was lower than control group when oxycodone was same or more than 0.1 mg/kg (P < 0.05). Using probit analysis, the 95% effective dose (ED(95)) for preventing hypertension was 0.159 mg/kg (95% confidence interval [CI], 0.122–0.243). In addition, ED(50) was 0.020 mg/kg (95% CI, −0.037 to 0.049). However, oxycodone was not effective for maintaining the HR in our study dosage. There were no significant differences in the incidence of hypotension during induction between groups. CONCLUSIONS: Using 0.1 mg/kg of intravenous oxycodone is sufficient to attenuate the increase of BP and HR during induction period in healthy patients. The ED(95), which was 0.159 mg/kg, can be useful to adjust the dosage of IV oxycodone for maintain stable BP during induction of general anesthesia. Wolters Kluwer Health 2017-03-24 /pmc/articles/PMC5369887/ /pubmed/28296732 http://dx.doi.org/10.1097/MD.0000000000006234 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 3300
Park, Yong-Hee
Lee, Seung-Hyuk
Lee, Oh Haeng
Kang, Hyun
Shin, Hwa-Yong
Baek, Chong-Wha
Jung, Yong Hun
Woo, Young Cheol
Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: A randomized controlled trial
title Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: A randomized controlled trial
title_full Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: A randomized controlled trial
title_fullStr Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: A randomized controlled trial
title_full_unstemmed Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: A randomized controlled trial
title_short Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: A randomized controlled trial
title_sort optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: a randomized controlled trial
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369887/
https://www.ncbi.nlm.nih.gov/pubmed/28296732
http://dx.doi.org/10.1097/MD.0000000000006234
work_keys_str_mv AT parkyonghee optimaldoseofintravenousoxycodoneforattenuatinghemodynamicchangesafterendotrachealintubationinhealthypatientsarandomizedcontrolledtrial
AT leeseunghyuk optimaldoseofintravenousoxycodoneforattenuatinghemodynamicchangesafterendotrachealintubationinhealthypatientsarandomizedcontrolledtrial
AT leeohhaeng optimaldoseofintravenousoxycodoneforattenuatinghemodynamicchangesafterendotrachealintubationinhealthypatientsarandomizedcontrolledtrial
AT kanghyun optimaldoseofintravenousoxycodoneforattenuatinghemodynamicchangesafterendotrachealintubationinhealthypatientsarandomizedcontrolledtrial
AT shinhwayong optimaldoseofintravenousoxycodoneforattenuatinghemodynamicchangesafterendotrachealintubationinhealthypatientsarandomizedcontrolledtrial
AT baekchongwha optimaldoseofintravenousoxycodoneforattenuatinghemodynamicchangesafterendotrachealintubationinhealthypatientsarandomizedcontrolledtrial
AT jungyonghun optimaldoseofintravenousoxycodoneforattenuatinghemodynamicchangesafterendotrachealintubationinhealthypatientsarandomizedcontrolledtrial
AT wooyoungcheol optimaldoseofintravenousoxycodoneforattenuatinghemodynamicchangesafterendotrachealintubationinhealthypatientsarandomizedcontrolledtrial